Understanding the role of transfonning growth factor-β 1 in intimal thickening after vascular injury

被引:100
作者
Khan, Razi
Agrotis, Alex
Bobik, Alex
机构
[1] Univ Western Ontario, Dept Internal Med, London, ON N6A 3M1, Canada
[2] Baker Heart Res Inst, Cell Biol Lab, Melbourne, Vic 3004, Australia
关键词
transforming growth factor-beta 1; intimal thickening; percutaneous coronary intervention; vascular smooth muscle cell; extracellular matrix; transforming growth factor beta 3; tranilast;
D O I
10.1016/j.cardiores.2007.02.012
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Intimal thickening is the most important cause of in-stent restenosis. The pathology of intimal thickening is attributable to a local inflammatory response after vascular injury which results in the production of cytokines. Transforming growth factor-beta 1 (TGF-beta 1) is a profibrotic cytokine that is involved in the induction of intimal thickening. Up-regulation of TGF-beta 1 after arterial injury results in the activation of various downstream pathways which stimulate the proliferation and migration of vascular smooth muscle cells, as well as the production of local extracellular matrix proteins. Recent evidence suggests that antagonizing TGF-beta 1 activity with direct or indirect inhibitors may attenuate or prevent intimal thickening. Additionally, TGF-beta 1 synthesis, activation and downstream regulation may also serve as significant sources of treatment. This review attempts to show the role of TGF-beta 1 in the pathology of intimal thickening and underlines the importance of TGF-beta 1 as a target for therapy. (c) 2007 European Society of Cardiology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:223 / 234
页数:12
相关论文
共 119 条
[1]
Agrotis Alex, 2005, Current Vascular Pharmacology, V3, P55, DOI 10.2174/1570161052773951
[2]
CYTOKINES AND GROWTH-FACTORS POSITIVELY AND NEGATIVELY REGULATE INTERSTITIAL COLLAGEN GENE-EXPRESSION IN HUMAN VASCULAR SMOOTH-MUSCLE CELLS [J].
AMENTO, EP ;
EHSANI, N ;
PALMER, H ;
LIBBY, P .
ARTERIOSCLEROSIS AND THROMBOSIS, 1991, 11 (05) :1223-1230
[3]
Chimeric DNA-RNA hammerhead ribozyme targeting transforming growth factor-β1 mRNA inhibits neointima formation in rat carotid artery after balloon injury [J].
Ando, H ;
Fukuda, N ;
Kotani, M ;
Yokoyama, S ;
Kunimoto, S ;
Matsumoto, K ;
Saito, S ;
Kanmatsuse, K ;
Mugishima, H .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 483 (2-3) :207-214
[4]
A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents [J].
Babapulle, MN ;
Joseph, L ;
Bélisle, P ;
Brophy, JM ;
Eisenberg, MJ .
LANCET, 2004, 364 (9434) :583-591
[5]
Locally delivered nanoencapsulated tyrphostin (AGL-2043) reduces neointima formation in balloon-injured rat carotid and stented porcine coronary arteries [J].
Banai, S ;
Chorny, M ;
Gertz, SD ;
Fishbein, I ;
Gao, JC ;
Perez, L ;
Lazarovichi, G ;
Gazit, A ;
Levitzki, A ;
Golomb, G .
BIOMATERIALS, 2005, 26 (04) :451-461
[6]
Liver fibrosis [J].
Bataller, R ;
Brenner, DA .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (02) :209-218
[7]
Transforming growth factor-βs and vascular disorders [J].
Bobik, Alex .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (08) :1712-1720
[8]
Progressive transforming growth factor β1-induced lung fibrosis is blocked by an orally active ALK5 kinase inhibitor [J].
Bonniaud, P ;
Margetts, PJ ;
Kolb, M ;
Schroeder, JA ;
Kapoun, AM ;
Damm, D ;
Murphy, A ;
Chakravarty, S ;
Dugar, S ;
Higgins, L ;
Protter, AA ;
Gauldie, J .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 171 (08) :889-898
[9]
STIMULATION OF MIGRATION OF HUMAN AORTIC SMOOTH-MUSCLE CELLS BY VITRONECTIN - IMPLICATIONS FOR ATHEROSCLEROSIS [J].
BROWN, SL ;
LUNDGREN, CH ;
NORDT, T ;
FUJII, S .
CARDIOVASCULAR RESEARCH, 1994, 28 (12) :1815-1820
[10]
TGFβ is active, and correlates with activators of TGFβ, following porcine coronary angioplasty [J].
Chamberlain, J ;
Gunn, J ;
Francis, SE ;
Holt, CM ;
Arnold, ND ;
Cumberland, DC ;
Ferguson, MWJ ;
Crossman, DC .
CARDIOVASCULAR RESEARCH, 2001, 50 (01) :125-136